Premium
Treating cannabis hyperemesis syndrome in adolescents
Publication year - 2020
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32882
Subject(s) - medicine , cannabis , anxiety , psychiatry , vomiting , pediatrics , cannabis dependence , nausea , depression (economics) , cannabidiol , economics , macroeconomics
Cannabis hyperemesis syndrome (CHS) is extreme vomiting after ingestion of cannabis; it has been seen in adult patients, but in adolescents, especially females, it may present more frequently, a recent literature search has shown. The review, “Diagnosis and acute management of adolescent cannabinoid hyperemesis syndrome,” published in the Journal of Adolescent Health, noted that 21% of adolescents diagnosed with CHS have a history of anxiety and depression. The only known effective treatment is complete cessation of cannabis use, but haloperidol and topical capsaicin cream may provide symptom relief in some cases. The study was conducted to synthesize qualitative and quantitative data on the diagnosis and treatment of CHS in adolescents. The literature review yielded 148 studies for full‐text review, of which 12 were included in the systematic review. Ten of these were related to the diagnosis of CHS, and 11 were related to treatment of adolescent cases of CHS.